Aspects of patient reported outcomes in rare diseases: a discussion paper

A Rüther, D Elstein, D Wong-Rieger… - International Journal of …, 2016 - cambridge.org
Objectives: A patient reported outcome (PRO) is “any report of the status of a patient's health
condition that comes directly from the patient without interpretation of the patient's response …

Patient-reported outcomes in clinical trials of rare diseases

E Basch, AV Bennett - Journal of general internal medicine, 2014 - Springer
The science of measuring patient-reported outcomes (PROs) has advanced substantially in
recent decades, allowing evaluation of how patients feel and function in clinical research …

Limited responsiveness related to the minimal important difference of patient-reported outcomes in rare diseases

BC Johnston, PA Miller, A Agarwal, S Mulla… - Journal of Clinical …, 2016 - Elsevier
Objectives To explore the responsiveness of patient-reported outcomes (PROs) in
interventional studies involving patients with rare lysosomal storage diseases (LSDs). Study …

The use of patient-reported outcome measures in rare diseases and implications for health technology assessment

A Whittal, M Meregaglia, E Nicod - The Patient-Patient-Centered …, 2021 - Springer
Background Patient-reported outcome measures (PROMs) are used in health technology
assessment (HTA) to measure patient experiences with disease and treatment, allowing a …

Generating health technology assessment evidence for rare diseases

K Facey, A Granados, G Guyatt, A Kent… - International journal of …, 2014 - cambridge.org
Objectives: Rare diseases are often heterogeneous in their progression and response to
treatment, with only a small population for study. This provides challenges for evidence …

Patient reported outcomes: an overview

A Nixon, D Wild, W Muehlhausen - 2015 - books.google.com
Patient reported outcomes (PROs) are a measurement based on a report that comes directly
from the patient about the status of their health condition without amendment or …

Sample size used to validate a scale: a review of publications on newly-developed patient reported outcomes measures

E Anthoine, L Moret, A Regnault, V Sébille… - Health and quality of life …, 2014 - Springer
Purpose New patient reported outcome (PRO) measures are regularly developed to assess
various aspects of the patients' perspective on their disease and treatment. For these …

Patient reported outcome measures in rare diseases: a narrative review

A Slade, F Isa, D Kyte, T Pankhurst, L Kerecuk… - Orphanet journal of rare …, 2018 - Springer
Background Rare diseases can lead to a significant reduction in quality of life for patients
and their families. Ensuring the patients voice is central to clinical decision making is key to …

Patient-reported outcome and observer-reported outcome assessment in rare disease trials

S Acaster - Value in Health, 2017 - valueinhealthjournal.com
The International Society for Pharmacoeconomics and Outcomes Research Task Force has
presented a detailed report highlighting the challenges associated with capturing clinical …

Pragmatic characteristics of patient-reported outcome measures are important for use in clinical practice

K Kroenke, PO Monahan, J Kean - Journal of clinical epidemiology, 2015 - Elsevier
Objectives Measures for assessing patient-reported outcomes (PROs) that may have initially
been developed for research are increasingly being recommended for use in clinical …